Synopsis

Source of validity: Scientific
Rating (out of 5): 3

Alpha-glycosyl isoquercitrin is a highly bioavailable form of quercetin, a flavonoid known for its antioxidant and vascular-protective properties. Scientific studies have demonstrated that quercetin and its derivatives, including alpha-glycosyl isoquercitrin, can exert beneficial effects on the circulatory system. Research indicates that these compounds may help improve endothelial function, promote vasodilation by influencing nitric oxide pathways, and reduce oxidative stress and inflammation, which are key contributors to cardiovascular disease. A 2013 study in Food & Function showed that alpha-glycosyl isoquercitrin had superior absorption compared to standard quercetin, leading to greater plasma concentrations and potential for biological activity.

While most human studies use general quercetin or isoquercitrin, not specifically the alpha-glycosylated form, the enhanced bioavailability of alpha-glycosyl isoquercitrin suggests that it could deliver similar or greater effects at lower doses. Some small-scale clinical trials and animal studies have reported reductions in blood pressure, improvement in lipid profiles, and decreased markers of vascular inflammation associated with quercetin supplementation. However, large-scale, long-term human trials specifically focusing on alpha-glycosyl isoquercitrin and cardiovascular outcomes are still limited. Therefore, while there is a scientific rationale and preliminary evidence supporting its use for circulatory health, the overall evidence base remains moderate and further research is needed to confirm efficacy.

More about alpha-glycosyl isoquercitrin
More about Circulatory System

Other ingredients that support Circulatory System

Other body systems supported by alpha-glycosyl isoquercitrin

Products containing alpha-glycosyl isoquercitrin